Grant: Discovery Grants Program - Individual
University of Alberta
$64,000.00
Mechanisms of Diphenylamine Xenobiotic Reactivity and Toxicity
EF 2024-25
Résumé
Background:
Diphenylamine (DPA) occurs both naturally and synthetically, and DPA derivatives (DPAs) have widespread industrial use, including in the manufacturing of dyes, rubbers, pesticides, pharmaceuticals, and are found in munition sites. As a result of their widespread use, DPAs also occur in wastewater treatment plants in Canada, and in fish. Xenobiotics like DPAs are not typically reactive but may be oxidized to produce reactive metabolites. The latter are of toxicological concern since they can weaken cells and cause damage to their proteins and DNA. This proposal focuses on unexplored pathways of DPAs metabolism and the ensuing biological consequences. The ubiquitous use and environmental occurrence of DPA derivatives necessitate these studies.
Rationale:
Preliminary studies have shown that some DPAs can form two types of reactive metabolites: free radical metabolites and hydroxylated metabolites. These metabolites were formed from the heme protein, myeloperoxidase (MPO), which is found in specific blood cells. However, MPO does not usually produce hydroxylated metabolites, and the latter can be further oxidized to quinone- like reactive metabolites. As such, there are fundamental questions about how MPO produces two different types of reactive metabolites. Moreover, metabolism studies using industrial antioxidant DPAs, which are massively produced and imported, have not been reported. Therefore, the potential of DPAs toxicity has not been thoroughly evaluated, nor is it known how relatively harmful different DPAs metabolites are compared to their unmetabolized precursors.
Hypotheses:
1) MPO can produce both free radical and hydroxylated metabolites of DPAs.
2) MPO enzymatic activity is a requirement for the toxicity of DPAs.
Aims:
1) To characterize the reactive metabolites formed from DPAs by isolated MPO and MPO-positive vs MPO-negative cells.
2) To determine the cellular effects and responses from DPAs in MPO-positive vs MPO-negative cells.
3) To determine damage of specific macromolecule (protein, DNA) intracellular targets by DPAs, and to carry out proteomic and metabolomic studies.
4) To understand the basis of metabolism and toxicity using structure-activity relationships.
Significance:
This proposal will reveal significant advances in our understanding of how MPO produces different reactive metabolites of DPAs, and evaluate their cellular toxicity pathways. As thousands of tonnes of DPAs being used in certain industrial processes, it is vital to study the effects of DPAs to appreciate their potential hazards. These research findings can contribute to government policymakers regarding the use of DPAs. The application of diverse techniques that involve analytical techniques, mechanistic toxicology, omics technologies, and computational analyses are proposed, which will benefit the training of highly qualified personnel in Canada.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2020-06305
Name nom
Siraki, Arno
Department département
Pharmacy and Pharmaceutical Science, Faculty of - Pharmacy and Pharmaceutical Science, Faculty of
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2020
Award amount
64000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
507
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Industrial chemicals (solvents, resins)
Area of application fr
Produits chimiques industriels (solvants, résines)
Research subject code
6403
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Toxicology
Research subject fr
Toxicologie
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Mechanisms of Diphenylamine Xenobiotic Reactivity and Toxicity
Keywords
myeloperoxidase; free radicals; diphenylamine; metabolism; reactive metabolites; cytotoxicity; electron paramagnetic resonance
Application summary
Background:
Diphenylamine (DPA) occurs both naturally and synthetically, and DPA derivatives (DPAs) have widespread industrial use, including in the manufacturing of dyes, rubbers, pesticides, pharmaceuticals, and are found in munition sites. As a result of their widespread use, DPAs also occur in wastewater treatment plants in Canada, and in fish. Xenobiotics like DPAs are not typically reactive but may be oxidized to produce reactive metabolites. The latter are of toxicological concern since they can weaken cells and cause damage to their proteins and DNA. This proposal focuses on unexplored pathways of DPAs metabolism and the ensuing biological consequences. The ubiquitous use and environmental occurrence of DPA derivatives necessitate these studies.
Rationale:
Preliminary studies have shown that some DPAs can form two types of reactive metabolites: free radical metabolites and hydroxylated metabolites. These metabolites were formed from the heme protein, myeloperoxidase (MPO), which is found in specific blood cells. However, MPO does not usually produce hydroxylated metabolites, and the latter can be further oxidized to quinone- like reactive metabolites. As such, there are fundamental questions about how MPO produces two different types of reactive metabolites. Moreover, metabolism studies using industrial antioxidant DPAs, which are massively produced and imported, have not been reported. Therefore, the potential of DPAs toxicity has not been thoroughly evaluated, nor is it known how relatively harmful different DPAs metabolites are compared to their unmetabolized precursors.
Hypotheses:
1) MPO can produce both free radical and hydroxylated metabolites of DPAs.
2) MPO enzymatic activity is a requirement for the toxicity of DPAs.
Aims:
1) To characterize the reactive metabolites formed from DPAs by isolated MPO and MPO-positive vs MPO-negative cells.
2) To determine the cellular effects and responses from DPAs in MPO-positive vs MPO-negative cells.
3) To determine damage of specific macromolecule (protein, DNA) intracellular targets by DPAs, and to carry out proteomic and metabolomic studies.
4) To understand the basis of metabolism and toxicity using structure-activity relationships.
Significance:
This proposal will reveal significant advances in our understanding of how MPO produces different reactive metabolites of DPAs, and evaluate their cellular toxicity pathways. As thousands of tonnes of DPAs being used in certain industrial processes, it is vital to study the effects of DPAs to appreciate their potential hazards. These research findings can contribute to government policymakers regarding the use of DPAs. The application of diverse techniques that involve analytical techniques, mechanistic toxicology, omics technologies, and computational analyses are proposed, which will benefit the training of highly qualified personnel in Canada.